The Patent Finder

Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor

Pharmacyclics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 12 of these applications claim priority to application PCT/US2013/043888, filed Jun 3, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,713,617Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor
In force
 · High confidence
Pharmacyclics LLCIn force
High confidence
US 9,725,455Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor
In force
 · High confidence
Pharmacyclics LLCIn force
High confidence
US 9,828,383Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor
In force
 · High confidence
Pharmacyclics LLCIn force
High confidence
US 10,065,968Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor
In force
 · Medium confidence
Pharmacyclics LLCIn force
Medium confidence
US 10,106,548Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor
In force
 · Medium confidence
Pharmacyclics LLCIn force
Medium confidence
US 10,125,140Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor
In force
 · High confidence
Pharmacyclics LLCIn force
High confidence
US 10,266,540Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor
In force
 · Medium confidence
Pharmacyclics LLCIn force
Medium confidence
US 10,294,231Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor
In force
 · Medium confidence
Pharmacyclics LLCIn force
Medium confidence
US 10,294,232Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor
In force
 · Medium confidence
Pharmacyclics LLCIn force
Medium confidence
US 10,752,634Crystalline Forms of a Brutons Tyrosine Kinase Inhibitor
In force
 · Low confidence
Pharmacyclics LLCIn force
Low confidence
6 more patents in this group · Pro
10 of 16 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 16.
Upgrade to Pro
12 of these are in force and held by Pharmacyclics, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited